Introduction Demographic change is resulting in a growing number of individuals requiring nursing care, while the ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Oct 28 (Reuters) - India's markets regulator has proposed changes to mutual fund fee structures as it sought a more transparent break-up of costs that investors are charged, according a consultation ...

How does our nose work? Have you wondered how we can detect so many different types of odors? There is chemistry behind food smells. In this activity, we will explore how small changes in chemical ...

In his 1960 book Theory and Design in the First Machine Age, the critic and historian Reyner Banham presciently noted a growing chasm between technological change and the capacity of designers to ...

Top U.S. senators have shared the outline of what they're after in the effort to establish rules of the road for domestic crypto markets, releasing a set of principles on Tuesday as they prepare to ...

Unlock the power of your data with an effective data governance framework for security, compliance, and decision-making. Data governance frameworks are structured approaches to managing and utilizing ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Prevent AI-generated tech debt with Skeleton ...

Structure Therapeutics' GSBR-1290 showed a placebo-adjusted mean weight loss of 6.2% at 12 weeks, suggesting potential despite initial underwhelming results. Comparatively, Eli Lilly’s orforglipron ...

I am a developer of open source. I have been an SRE for the last 10 years, of which I have been a team leader 5 years. I am a developer of open source. I have been an SRE for the last 10 years, of ...